Entering text into the input field will update the search result below

Peregrine Pharmaceuticals beats by $0.01, beats on revenue

  • Peregrine Pharmaceuticals (PPHM): FQ4 EPS of -$0.07 beats by $0.01.
  • Revenue of $9.3M (+43.7% Y/Y) beats by $2.88M.
  • Press Release

Recommended For You

About CDMO Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
CDMO--
Avid Bioservices, Inc.